Advancing speech activity detection for automatic speech assessment of pre-school children prompted speech using COMBO-SAD von Dutta, Satwik, Kothalkar, Prasanna, Rudolph, Johanna, Dollaghan, Christine, McGlothlin, Jennifer, Campbell, Thomas, Hansen, John H.

Volltext

Advancing clinical group verification framework for screening child speech sound disorders using “text-independent” i-Vectors von Kothalkar, Prasanna V., Rudolph, Johanna M., Dollaghan, Christine, McGlothlin, Jennifer, Campbell, Thomas F., Hansen, John H. L.

Volltext

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage von Pradilla, Gustavo, Ratcliff, Jonathan J., Hall, Alex J., Saville, Benjamin R., Allen, Jason W., Paulon, Giorgio, McGlothlin, Anna, Lewis, Roger J., Fitzgerald, Mark, Caveney, Angela F., Li, Xiao T., Bain, Mark, Gomes, Joao, Jankowitz, Brain, Zenonos, Georgios, Molyneaux, Bradley J., Davies, Jason, Siddiqui, Adnan, Chicoine, Michael R., Keyrouz, Salah G., Grossberg, Jonathan A., Shah, Mitesh V., Singh, Ranjeet, Bohnstedt, Bradley N., Frankel, Michael, Wright, David W., Barrow, Daniel L.

Volltext

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe von Tong, Steven Y C, Mora, Jocelyn, Bowen, Asha C, Cheng, Matthew P, Daneman, Nick, Goodman, Anna L, Heriot, George S, Lee, Todd C, Lewis, Roger J, Lye, David C, Mahar, Robert K, Marsh, Julie, McGlothlin, Anna, McQuilten, Zoe, Morpeth, Susan C, Paterson, David L, Price, David J, Roberts, Jason A, Robinson, J Owen, van Hal, Sebastiaan J, Walls, Genevieve, Webb, Steve A, Whiteway, Lyn, Yahav, Dafna, Davis, Joshua S

Volltext

Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol von de Kretser, Dana, Mora, Jocelyn, Bloomfield, Max, Campbell, Anita, Cheng, Matthew P, Guy, Stephen, Hensgens, Marjolein, Kalimuddin, Shirin, Lee, Todd C, Legg, Amy, Mahar, Robert K, Marks, Michael, Marsh, Julie, McGlothin, Anna, Morpeth, Susan C, Sud, Archana, Ten Oever, Jaap, Yahav, Dafna, Bonten, Marc, Bowen, Asha C, Daneman, Nick, van Hal, Sebastiaan J, Heriot, George S, Lewis, Roger J, Lye, David C, McQuilten, Zoe, Paterson, David L, Owen Robinson, J, Roberts, Jason A, Scarborough, Matthew, Webb, Steve A, Whiteway, Lynda, Tong, Steven Y C, Davis, Joshua S, Walls, Genevieve, Goodman, Anna L

Volltext

Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer von Infante, Jeffrey R., Patnaik, Amita, Verschraegen, Claire F., Olszanski, Anthony J., Shaheen, Montaser, Burris, Howard A., Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Hynes, Scott M., Leohr, Jennifer, Lin, Aimee Bence, Li, Lily Q., McGlothlin, Anna, Farrington, Daphne L., Westin, Eric H., Cohen, Roger B.

Volltext

Interventions for Speech Sound Disorders in Children von Williams, A

Volltext

Abstract A86: A phase 1 study of LY2523355, an Eg5 inhibitor, administered on Days 1, 2, and 3 with or without pegfilgrastim in patients with advanced malignancy (NCT01214629) von Verschraegen, Claire, Cohen, Roger B., Olszanski, Anthony J., Shaheen, Montaser, Nishida, Yuko, Bauman, Julie, Li, Lily, Brandt, John T., Nasir, Aejaz, Hynes, Scott M., Leohr, Jennifer K., McGlothlin, Anna, Westin, Eric H.

Volltext